Literature DB >> 12139628

Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans.

Frédérique Moyrand1, Birgit Klaproth, Uwe Himmelreich, Françoise Dromer, Guilhem Janbon.   

Abstract

The capsule of Cryptococcus neoformans is the most obvious virulence factor of this pathogenic yeast. The main capsule constituents are glucuronoxylomannans (GXM). Although several studies have focused on GXM composition and structure, very little is known about their genetics. To elucidate the relationship between the capsule structure and the pathophysiology of the cryptococcosis, genetic screening for mutant strains producing a structurally modified capsule was set up. Using monoclonal antibodies specific for different capsule sugar epitopes, we isolated strains with different mutated capsule structures (Cas mutants). According to their reactivities with various monoclonal antibodies, the mutants were classified into six groups (Cas1 to Cas6). One Cas2 mutant was used to clone the corresponding gene by complementation. This gene (USX1) encodes the previously identified UDP-xylose synthase. We demonstrated that it is necessary for both capsule xylosylation and C. neoformans virulence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139628     DOI: 10.1046/j.1365-2958.2002.03059.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  51 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

Review 2.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

3.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

4.  Gene disruption in Cryptococcus neoformans and Cryptococcus gattii by in vitro transposition.

Authors:  Guanggan Hu; James W Kronstad
Journal:  Curr Genet       Date:  2006-01-06       Impact factor: 3.886

5.  CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans.

Authors:  Y C Chang; A Jong; S Huang; P Zerfas; K J Kwon-Chung
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

7.  Cas3p belongs to a seven-member family of capsule structure designer proteins.

Authors:  Frédérique Moyrand; Yun C Chang; Uwe Himmelreich; Kyung J Kwon-Chung; Guilhem Janbon
Journal:  Eukaryot Cell       Date:  2004-12

8.  Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides.

Authors:  J Stacey Klutts; Tamara L Doering
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

9.  Beta1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids.

Authors:  Sherry A Castle; Elizabeth A Owuor; Stephanie H Thompson; Michelle R Garnsey; J Stacey Klutts; Tamara L Doering; Steven B Levery
Journal:  Eukaryot Cell       Date:  2008-08-01

10.  A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.

Authors:  Emma J Griffiths; Guanggan Hu; Bettina Fries; Mélissa Caza; Joyce Wang; Joerg Gsponer; Marcellene A Gates-Hollingsworth; Thomas R Kozel; Louis De Repentigny; James W Kronstad
Journal:  Mol Microbiol       Date:  2012-11-01       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.